Literature DB >> 26740514

First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever.

Amélie Menard1, Philippe Colson2, Dhiver Catherine1, Ravaux Isabelle1, Tomei Christelle1, Line Meddeb1, Souad Ben Ali3, Caroline Solas4, Andreas Stein5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26740514     DOI： 10.1093/cid/civ1215

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

Review 1.  Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States.

Authors:  Mary Clare Masters; Karen M Krueger; Janna L Williams; Lindsay Morrison; Susan E Cohn
Journal:  Expert Rev Clin Pharmacol       Date:  2019-12       Impact factor: 5.045

2.  Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world.

Authors:  Moisés Uriarte-Pinto; Herminia Navarro-Aznarez; Natalia De La Llama-Celis; Piedad Arazo-Garcés; Ana María Martínez-Sapiña; María Reyes Abad-Sazatornil
Journal:  Int J Clin Pharm       Date:  2018-03-20

3.  Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.

Authors:  David Wyles; Norbert Bräu; Shyam Kottilil; Eric S Daar; Peter Ruane; Kimberly Workowski; Anne Luetkemeyer; Oluwatoyin Adeyemi; Arthur Y Kim; Brian Doehle; K C Huang; Erik Mogalian; Anu Osinusi; John McNally; Diana M Brainard; John G McHutchison; Susanna Naggie; Mark Sulkowski
Journal:  Clin Infect Dis       Date:  2017-07-01       Impact factor: 9.079
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.